Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419. On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear.&nb...
I tiakina i:
Ngā kaituhi matua: | , , , , , , , , , , , , , , , |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
Dove Medical Press,
2015-11-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Whakarāpopototanga: | Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419. On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear. View original article by Yin et al. |
---|---|
Whakaahutanga tūemi: | 1177-8881 |